These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7996950)

  • 21. Memories of my research into von Willebrand's disease.
    Blombäck M
    Haemophilia; 2012 Jan; 18(1):3-6. PubMed ID: 22188572
    [No Abstract]   [Full Text] [Related]  

  • 22. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-vessel wall interaction: from the bedside to molecules.
    Caen JP; Rosa JP
    Thromb Haemost; 1995 Jul; 74(1):18-24. PubMed ID: 8578453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Von Willebrand disease: a common and unrecognized bleeding disorder].
    Boehlen F; Robert-Ebadi H; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).
    Federici AB
    Haemophilia; 2008 Jan; 14 Suppl 1():5-14. PubMed ID: 18173689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the way to virus-safe blood coagulation factor concentrates.
    Schimpf K
    Semin Thromb Hemost; 2002 Apr; 28 Suppl 1():15-24. PubMed ID: 12016574
    [No Abstract]   [Full Text] [Related]  

  • 27. Haemate P von Willebrand factor/factor VIII concentrate: 25 years of clinical experience.
    Schramm W
    Haemophilia; 2008 Nov; 14 Suppl 5():3-10. PubMed ID: 18786006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A pedigree of von Willebrand's syndrome].
    Hasegawa H; Ota Y; Watanabe N; Nagahama F
    Nihon Rinsho; 1967 May; 25(5):942-5. PubMed ID: 5299946
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent investigations of the first bleeder family in Aland (Finland) described by von Willebrand.
    Nyman D; Eriksson AW; Blombäck M; Frants RR; Wahlberg P
    Thromb Haemost; 1981 Feb; 45(1):73-6. PubMed ID: 6972630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Von Willebrand's disease.
    Hoyer LW
    Prog Hemost Thromb; 1976; 3():231-87. PubMed ID: 781732
    [No Abstract]   [Full Text] [Related]  

  • 31. Erik Jorpes (1894-1973). A tribute.
    Blombäck B; Copley AL
    Thromb Res; 1975 Jul; 7(1):1-2. PubMed ID: 1098218
    [No Abstract]   [Full Text] [Related]  

  • 32. Re-evaluation of three Israeli families initially diagnosed with type 1 von Willebrand disease in light of the ISTH update on von Willebrand factor pathophysiology and classification.
    Hashemi Soteh SM; Anson J; Inbal A; Peake IR; Goodeve AC
    Haemophilia; 2008 May; 14(3):621-4. PubMed ID: 18384353
    [No Abstract]   [Full Text] [Related]  

  • 33. Time to seek further clarity in the molecular analysis of von Willebrand disease?
    Favaloro EJ
    Thromb Haemost; 2009 Jul; 102(1):175-7. PubMed ID: 19572084
    [No Abstract]   [Full Text] [Related]  

  • 34. In search of Alexander A. Maximow: the man behind the unitarian theory of hematopoiesis.
    Konstantinov IE
    Perspect Biol Med; 2000; 43(2):269-76. PubMed ID: 10804590
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diagnosis of hemophilia and von Willebrand-Jürgens syndrome. 3. Results of studies on patients with vWJS, heterozygotes of vWJS and patients with Glanzmann-Naegeli thrombasthenia].
    Lutze G; Schlote A
    Z Gesamte Inn Med; 1985 Sep; 40(18):532-9. PubMed ID: 3878049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In memory of Erik Jorpes. von Willebrand's disease from 1926-1983.
    Nilsson IM
    Scand J Haematol Suppl; 1984; 40():21-43. PubMed ID: 6433454
    [No Abstract]   [Full Text] [Related]  

  • 37. The platelet aggregation defect in the von Willebrand-Jürgens-Syndrom on the Aland Islands. The possible existence of an "anti-Willebrand-Factor".
    Jürgens J; Lehmann W; Eriksson A
    Hemostase; 1966 Oct; 6(4):225-31. PubMed ID: 5299356
    [No Abstract]   [Full Text] [Related]  

  • 38. [A family with von Willebrand disease and hypofibrinogenemia].
    Shinmyozu K; Okadome T; Maruyama Y; Maruyama I; Osame M
    Rinsho Ketsueki; 1990 Sep; 31(9):1463-7. PubMed ID: 2246818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Barthels M; Budde U
    Hamostaseologie; 2005 Nov; 25(4):367-75. PubMed ID: 16395486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
    Hilbert L; Fressinaud E; Ribba AS; Meyer D; Mazurier C;
    Thromb Haemost; 2002 Apr; 87(4):635-40. PubMed ID: 12008946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.